HIV Dental Study, 5,603 Patients, Pays de la Loire
ClinicalTrials.gov Studies
Summary
A retrospective observational study (NCT07552038) will analyze anonymized data from 5,603 HIV-positive patients in the Pays de la Loire region of France to determine what proportion may require adapted dental management based on immune status, hematological values, and comorbidities. The COREVIH Pays de la Loire database will serve as the data source. Study aims to provide objective data to inform dental practice and reduce unnecessary precautions or stigmatization when treating HIV-positive patients.
“The results are expected to provide objective data to better inform dental practice and reduce unnecessary precautions or stigmatization in the management of patients living with HIV.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
ClinicalTrials.gov has registered a new observational study titled 'Dental Management of Patients With HIV in Pays de la Loire' (NCT07552038), posted April 27, 2026. The study is a retrospective descriptive analysis using anonymized patient data from the COREVIH Pays de la Loire database. The study examines whether HIV-positive patients require adapted dental management based on biological parameters including immune status, hematological values, and comorbidities.
This registry entry does not create compliance obligations or regulatory requirements. Healthcare researchers studying HIV care pathways or dental management protocols for immunocompromised patients may find this study relevant to their clinical practice. The study focuses specifically on the French Pays de la Loire region and may inform evidence-based approaches to reducing unnecessary clinical precautions in HIV dental care.
Archived snapshot
Apr 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Dental Management of Patients With HIV in Pays de la Loire
Observational NCT07552038 Kind: OBSERVATIONAL Apr 27, 2026
Abstract
Dental care for people living with HIV has evolved with the widespread use of antiretroviral therapy, which has improved life expectancy and disease control. However, uncertainty remains about whether specific adaptations are still needed during dental procedures due to potential biological abnormalities that may increase infectious or bleeding risks.
This study aims to evaluate the proportion of patients living with HIV in the Pays de la Loire region who may require adapted dental management based on biological parameters such as immune status, hematological values, and comorbidities.
A retrospective descriptive study will be conducted using anonymized data from 5,603 patients followed in the COREVIH Pays de la Loire database. The results are expected to provide objective data to better inform dental practice and reduce unnecessary precautions or stigmatization in the management of patients living with HIV.
Conditions: HIV Infection, Acquired Immune Deficiency Syndrome, Oral Health Care
Interventions: HIV infection status and clinical characteristics
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.